A detailed history of Bayesian Capital Management, LP transactions in Zoetis Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 5,400 shares of ZTS stock, worth $889,379. This represents 0.13% of its overall portfolio holdings.

Number of Shares
5,400
Previous 13,400 59.7%
Holding current value
$889,379
Previous $2.32 Million 54.58%
% of portfolio
0.13%
Previous 0.27%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$172.58 - $196.48 $1.38 Million - $1.57 Million
-8,000 Reduced 59.7%
5,400 $1.06 Million
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $523,944 - $643,788
3,600 Added 36.73%
13,400 $2.32 Million
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $1.62 Million - $1.96 Million
9,800 New
9,800 $1.66 Million
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $3.24 Million - $3.98 Million
-21,821 Reduced 94.06%
1,379 $204,000
Q2 2022

Aug 15, 2022

BUY
$155.97 - $200.09 $3.62 Million - $4.64 Million
23,200 New
23,200 $3.99 Million
Q2 2020

Aug 14, 2020

SELL
$111.92 - $142.53 $295,916 - $376,849
-2,644 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$92.66 - $144.94 $62,174 - $97,254
671 Added 34.01%
2,644 $311,000
Q4 2019

Feb 14, 2020

SELL
$116.25 - $133.25 $642,513 - $736,472
-5,527 Reduced 73.69%
1,973 $261,000
Q3 2019

Nov 13, 2019

BUY
$112.57 - $128.43 $844,275 - $963,225
7,500 New
7,500 $934,000
Q2 2019

Aug 13, 2019

SELL
$97.98 - $114.28 $1.42 Million - $1.65 Million
-14,463 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$81.56 - $100.67 $391,651 - $483,417
4,802 Added 49.7%
14,463 $1.46 Million
Q4 2018

Feb 13, 2019

BUY
$79.28 - $95.27 $765,924 - $920,403
9,661 New
9,661 $826,000
Q2 2018

Aug 14, 2018

SELL
$79.9 - $89.2 $711,110 - $793,880
-8,900 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$71.51 - $84.69 $557,778 - $660,582
-7,800 Reduced 46.71%
8,900 $743,000
Q4 2017

Feb 12, 2018

BUY
$63.24 - $72.8 $1.06 Million - $1.22 Million
16,700
16,700 $1.2 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.